These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1802898)

  • 21. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen/fibrin in atherogenesis.
    Smith EB; Thompson WD; Crosbie L; Stirk CM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative N-terminal analysis of fibrinogen-fibrin-related antigen [FR antigen] from human plasma.
    Harris JU; Johnson AJ; Merskey C; Wang MT; Robinson D
    Biochem J; 1979 Dec; 183(3):623-32. PubMed ID: 540036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction between fibrinogen and fibrin degradation products in plasma.
    Gaffney PJ
    Clin Chim Acta; 1975 Nov; 65(1):109-15. PubMed ID: 1192601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogenolysis and fibrinolysis with strenuous exercise.
    Ferguson EW; Barr CF; Bernier LL
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Dec; 47(6):1157-61. PubMed ID: 536284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
    Smith EB
    Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.
    Kudryk BJ; Bini A; Rosebrough SF; Schaible TF
    Biotechnology; 1991; 19():281-313. PubMed ID: 1723912
    [No Abstract]   [Full Text] [Related]  

  • 29. Fate of fibrinogen in human arterial intima.
    Smith EB; Keen GA; Grant A; Stirk C
    Arteriosclerosis; 1990; 10(2):263-75. PubMed ID: 2317160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of fibrin(ogen) fragments in gingival crevicular fluid.
    Talonpoika J
    Scand J Dent Res; 1991 Feb; 99(1):40-3. PubMed ID: 2047751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
    Francis CW; Connaghan DG; Scott WL; Marder VJ
    Circulation; 1987 Jun; 75(6):1170-7. PubMed ID: 3568326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
    Belitskaia GA; Palienko IA; Shevchenko LI; Fedorova NE
    Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
    Dempfle CE; Wurst M; Smolinski M; Lorenz S; Osika A; Olenik D; Fiedler F; Borggrefe M
    Thromb Haemost; 2004 Apr; 91(4):812-8. PubMed ID: 15045145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis.
    Bone JM; Sherman LA; Valdes AJ; Lubowitz H
    J Lab Clin Med; 1977 May; 89(5):1043-52. PubMed ID: 558266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isolation of the fragment D dimer from stabilized fibrin and a study of its antipolymerization action].
    Musialkovskaia AA; Khodorova EL; Pozdniakova TM
    Ukr Biokhim Zh; 1976; 48(2):139-43. PubMed ID: 941302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody to fibrin D-dimer (DD-3B6) recognizes an epitope on the gamma-chain of fragment D.
    Devine DV; Greenberg CS
    Am J Clin Pathol; 1988 May; 89(5):663-6. PubMed ID: 2451885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digestion of 125I-labelled plasmin-derived fibrin degradation products by neutrophil lysosomal enzymes.
    Adams SA; Kelly SL; Kirsch RE; Shephard EG
    Blood Coagul Fibrinolysis; 1998 Jun; 9(4):307-13. PubMed ID: 9690801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma).
    Lee P; Norman CS; Sukenik S; Alderdice CA
    J Rheumatol; 1985 Jun; 12(3):514-7. PubMed ID: 2931522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.